Home / FDA Grants Orphan Drug Designation to Elraglusib for Soft Tissue Sarcomas
Read the story
Don’t be the last to know! Join over 50,000 members of the sarcoma community who get the latest research updates, information about treatments and trials, education opportunities and ways to get involved.
